{"id":5986,"date":"2026-10-12T16:27:22","date_gmt":"2026-10-12T14:27:22","guid":{"rendered":"https:\/\/blog.lallianse.com\/?p=5986"},"modified":"2026-10-12T16:49:48","modified_gmt":"2026-10-12T14:49:48","slug":"big-2026-by-bpifrance-2","status":"publish","type":"post","link":"https:\/\/blog.lallianse.com\/index.php\/en\/big-2026-by-bpifrance-2\/","title":{"rendered":"BIG 2026 by bpifrance"},"content":{"rendered":"\n

[#BIG2026<\/a>] Can an innovation be excellent\u2026 without ever being ordered?<\/strong><\/mark><\/p>\n\n\n\n

A key paradox emerged from the #conversation we moderated yesterday at #BIG, centered on a simple question: how do we create viable demand to accelerate #deeptech in healthcare?

Because there is a long journey between a relevant, available solution and that first order:
\u2192 a value proposition to build for all stakeholders
\u2192 a healthcare facility that must mobilize time, teams, and a budget to run a pilot
\u2192 a procurement process to understand, anticipate, and coordinate
\u2192 a contractual framework that needs to be in place
\u2192 a manufacturer that is still in business to issue the invoice!<\/p>\n\n\n\n

Ultimately, it requires orchestrating #alignment among the decision-maker, the payer, the prescriber, the beneficiary, and the end-user…<\/p>\n\n\n\n

Market access is an integral part of the investment narrative (equity story) and cannot be considered only after commercial authorizations are granted. Evidence, the decision-making process, the budget, and the procurement pathway must all be prepared together, as early as possible.<\/p>\n\n\n\n

Thanks to Noa Bach<\/a> (AP-HP, Assistance Publique – H\u00f4pitaux de Paris<\/a>), Peggy Rematier<\/a> (Bpifrance<\/a>), Julie Rachline<\/a> (LallianSe – Catalyseur d’action(s)<\/a> & ex #Braintale<\/a> wearing two hats) Louis Potel<\/a> (Resah<\/a>) and Hicham CHEHADE<\/a> (OPTACARE<\/a>) for their highly complementary insights and experiences… and, of course, to the audience for actively participating in the Q&A and voting throughout the discussion !<\/p>\n\n\n\n

A topic that clearly deserves further exploration: how can we shorten the time between an innovation becoming available and its actual use?

#Healthcare<\/a>#Innovation<\/a>#bpifrance<\/a>#mod\u00e9ration<\/a>#dialogue<\/a><\/p>\n\n\n\n

Julie Rachline<\/a>Shahrzad Moradi<\/a>Maryline BROWNE-DIGUERHER<\/a>David Marques<\/a>Olivier Chabanon<\/a>La French Care<\/a>Bpifrance<\/a><\/p>\n\n\n\n

\n\n\n\n